Agfa-Gevaert NV (LON:0MFU)
0.8470
+0.0100 (1.19%)
At close: Oct 24, 2025
Agfa-Gevaert NV Revenue
Agfa-Gevaert NV had revenue of 281.00M EUR in the quarter ending June 30, 2025, a decrease of -1.75%. This brings the company's revenue in the last twelve months to 1.13B, down -0.35% year-over-year. In the year 2024, Agfa-Gevaert NV had annual revenue of 1.14B, down -1.04%.
Revenue (ttm)
1.13B EUR
Revenue Growth
-0.35%
P/S Ratio
0.12
Revenue / Employee
236.10K EUR
Employees
4,765
Market Cap
114.51M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.14B | -12.00M | -1.04% |
| Dec 31, 2023 | 1.15B | 5.00M | 0.44% |
| Dec 31, 2022 | 1.15B | -615.00M | -34.94% |
| Dec 31, 2021 | 1.76B | 51.00M | 2.98% |
| Dec 31, 2020 | 1.71B | -266.00M | -13.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |